Sanne Wass

Stay informed with Sanne Wass’s coverage and analysis.

Chairman of Naalakkersuisut in Greenland Mute B Egede holds a press conference with Denmark’s Prime Minister in Copenhagen on January 10, 2025, amid the current remarks of the US president-elect. (Photo by Mads Claus Rasmussen / Ritzau Scanpix / AFP) / Denmark OUT (Photo by MADS CLAUS RASMUSSEN/Ritzau Scanpix/AFP via Getty Images)

Greenland is ready to cooperate with Trump, Premier says

By Sara Sjolin, Sanne Wass, and others

Danish Prime Minister Mette Frederiksen, also leader of Denmark’s Social Democrats, speaks at the party’s congress in Aalborg on September 14, 2024. (Photo by Henning Bagger / Ritzau Scanpix / AFP) / Denmark OUT (Photo by HENNING BAGGER/Ritzau Scanpix/AFP via Getty Images)

Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’

By Sara Sjolin, Sanne Wass, and others

Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, at the company’s headquarters during a Bloomberg Television interview in Bagsvaerd, Denmark, on Friday, May 3, 2024. Novo has a greater impact on Denmark’s employment levels than previously estimated, according to the state’s fiscal watchdog, aggravating concerns the Nordic economy is becoming too dependent on the pharmaceutical giant. Photographer: Nanna Navntoft/Bloomberg via Getty Images

Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict

By Sanne Wass and Bloomberg

Denmark’s Prime Minister Mette Frederiksen addresses participants of the 7th annual Copenhagen Democracy Summit at the Royal Danish Playhouse in Copenhagen on May 14, 2024. (Photo by Ida Marie Odgaard / Ritzau Scanpix / AFP) / Denmark OUT (Photo by IDA MARIE ODGAARD/Ritzau Scanpix/AFP via Getty Images)

Denmark forms ‘crisis ministry’ to combat spying and cyberattacks as Russian threat intensifies

By Sanne Wass and Bloomberg

Novo Nordisk and Bavarian Nordic are headquartered in Denmark.

Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy

By Sanne Wass and Bloomberg

Plumes of smoke are seen after a fire broke out at an office building belonging to Danish pharmaceutical group Novo Nordisk in Bagsvaerd near Copenhagen, Denmark, on May 22, 2024.

Danish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out

By Sanne Wass, Naomi Kresge, and others

Photo of two boys riding in a cargo bike with their mother in downtown of Copenhagen

Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency

By Sanne Wass and Bloomberg

Novo Nordisk CEO Lars Fruergaard Jorgensen Interview

Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark

By Sanne Wass, Naomi Kresge, and others

Prime Minister of Denmark Mette Frederiksen.

This Nordic country just added $6 billion to defense and will start drafting women into its military service, to help counter threat from Russia

By Sanne Wass and Bloomberg

The Danish company will begin its global rollout with the international supermarket chain SPAR.

AI’s latest task is helping supermarkets safely unload soon-to-expire food

By Sanne Wass and Bloomberg

WASHINGTON, DC – SEPTEMBER 13: Elon Musk, CEO of Tesla and X, arrives for the “AI Insight Forum” outside the Kennedy Caucus Room in the Russell Senate Office Building on Capitol Hill on September 13, 2023 in Washington, DC. Lawmakers are seeking input from business leaders in the artificial intelligence sector, and some of their most ardent opponents, for writing legislation governing the rapidly evolving technology. (Photo by Chip Somodevilla/Getty Images)

Elon Musk’s showdown with Nordic labor deepens as a pension fund dumps Tesla shares and postal workers withhold mail

By Sanne Wass, Christian Wienberg, and others

Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company’s headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that will intensify competition. Photographer: Carsten Snejbjerg/Bloomberg via Getty Images

Novo Nordisk employees who need to lose weight get an unusual perk—free Wegovy that normally costs $4,400 annually

By Sanne Wass and Bloomberg